Accelerating Diagnostics in a Time of Crisis
The Response to COVID-19 and a Roadmap for Future Pandemics
Herausgeber: Schachter, Steven C.; Bolton, Wade E.
Accelerating Diagnostics in a Time of Crisis
The Response to COVID-19 and a Roadmap for Future Pandemics
Herausgeber: Schachter, Steven C.; Bolton, Wade E.
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
By presenting chapter-specific roadmaps, this book offers a behind-the-scenes chronology of the response to COVID-19 and provides a rubric for future pandemic response. Targeted at lay and scientific audiences, reflections and lessons learned grant the reader an opportunity to leverage this knowledge and improve the outcomes of future pandemics.
Andere Kunden interessierten sich auch für
- Welch, H. Gilbert, M.D., M.P.H.Overdiagnosed24,99 €
- Ben Lovell (University Coll Consultant Physician in Acute MedicineEureka: Clinical Skills, Diagnostics and Reasoning49,99 €
- The Advanced Practitioner in Pathophysiology and Diagnostics43,99 €
- Tim Wreghitt (Addenbrookeâ s Hospital)Clinical and Diagnostic Virology74,99 €
- Peter M. HowleyFields Virology Volume 4: Fundamentals108,99 €
- Laurie GarrettThe Coming Plague31,99 €
- Romilly HodgesImmune Resilience21,99 €
-
-
-
By presenting chapter-specific roadmaps, this book offers a behind-the-scenes chronology of the response to COVID-19 and provides a rubric for future pandemic response. Targeted at lay and scientific audiences, reflections and lessons learned grant the reader an opportunity to leverage this knowledge and improve the outcomes of future pandemics.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 300
- Erscheinungstermin: 7. März 2024
- Englisch
- Abmessung: 153mm x 234mm x 19mm
- Gewicht: 460g
- ISBN-13: 9781009396981
- ISBN-10: 1009396986
- Artikelnr.: 68654995
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Cambridge University Press
- Seitenzahl: 300
- Erscheinungstermin: 7. März 2024
- Englisch
- Abmessung: 153mm x 234mm x 19mm
- Gewicht: 460g
- ISBN-13: 9781009396981
- ISBN-10: 1009396986
- Artikelnr.: 68654995
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
Introduction Tania Fernandez; 1. Early detection
response
and surveillance of the covid-19 pandemic crisis Enrique Rabellino
Alexandra Smith and Marta Cohen; 2. Immune system responses to SARS-CoV-2 Adolfo Firpo-Betancourt; 3. Clinical management: a roadmap for one nyc hospital's response to the covid-19 pandemic Barbara Barnett
Yvette Calderon
Erick Eiting
Young Lee
Lina Miyakawa
Waleed Javaid and Saralynne Brown; 4. Contribution of radx to the rapid development and commercialization of covid-19 diagnostic assays Steven Schachter
John Collins
Michael Dempsey
Laura Gibson
Matthew Robinson and Paul Tessier; 5. Coordination of resources for the deployment of covid-19 diagnostic assays Brian Walsh
Maren Downing
Mia Cirrincoine
Adam Samuta
Kevin Leite
Sam Dolphin
Emily Muth and Jose Valdesuso; 6. Quality and risk management processes for diagnostic assays during an emergency pandemic response¿ Devon Campbell and Christie Johnson; 7. Development of assays to diagnose covid-19 Yuka Manabe and William Clarke; 8. Laboratory verification and clinical validation of covid-19 diagnostic assays Wilbur Lam
Leda Bassit
Anuradha Rao
Jennifer Frediani and Julie Sullivan; 9. Importance of timely sequencing
tracking and surveillance of emergent variants Anne Piantadosi
Jessica Lin
Morgan Greenleaf
Leda Bassit
Cassandra Wesselman and Yang Lu; 10. The RADx regulatory core and its role in covid-19 emergency use authorizations Erika Tyburski and Cathy Cambria; 11. Commercialization and market assessment of covid-19 assays Manuel Kingsley
Sunshine Moore and Heath Naquin; 12. Testing strategies to mitigate covid-19 disease spread Paul Tessier and Peko Hosoi; 13. A pandemic not just of infection but of inequality: the social impact of covid-19 Mara Aspinall and Liz Ruark; 14. Summary and path forward for future pandemics Wade Bolton and Steven Schachter.
response
and surveillance of the covid-19 pandemic crisis Enrique Rabellino
Alexandra Smith and Marta Cohen; 2. Immune system responses to SARS-CoV-2 Adolfo Firpo-Betancourt; 3. Clinical management: a roadmap for one nyc hospital's response to the covid-19 pandemic Barbara Barnett
Yvette Calderon
Erick Eiting
Young Lee
Lina Miyakawa
Waleed Javaid and Saralynne Brown; 4. Contribution of radx to the rapid development and commercialization of covid-19 diagnostic assays Steven Schachter
John Collins
Michael Dempsey
Laura Gibson
Matthew Robinson and Paul Tessier; 5. Coordination of resources for the deployment of covid-19 diagnostic assays Brian Walsh
Maren Downing
Mia Cirrincoine
Adam Samuta
Kevin Leite
Sam Dolphin
Emily Muth and Jose Valdesuso; 6. Quality and risk management processes for diagnostic assays during an emergency pandemic response¿ Devon Campbell and Christie Johnson; 7. Development of assays to diagnose covid-19 Yuka Manabe and William Clarke; 8. Laboratory verification and clinical validation of covid-19 diagnostic assays Wilbur Lam
Leda Bassit
Anuradha Rao
Jennifer Frediani and Julie Sullivan; 9. Importance of timely sequencing
tracking and surveillance of emergent variants Anne Piantadosi
Jessica Lin
Morgan Greenleaf
Leda Bassit
Cassandra Wesselman and Yang Lu; 10. The RADx regulatory core and its role in covid-19 emergency use authorizations Erika Tyburski and Cathy Cambria; 11. Commercialization and market assessment of covid-19 assays Manuel Kingsley
Sunshine Moore and Heath Naquin; 12. Testing strategies to mitigate covid-19 disease spread Paul Tessier and Peko Hosoi; 13. A pandemic not just of infection but of inequality: the social impact of covid-19 Mara Aspinall and Liz Ruark; 14. Summary and path forward for future pandemics Wade Bolton and Steven Schachter.
Introduction Tania Fernandez; 1. Early detection
response
and surveillance of the covid-19 pandemic crisis Enrique Rabellino
Alexandra Smith and Marta Cohen; 2. Immune system responses to SARS-CoV-2 Adolfo Firpo-Betancourt; 3. Clinical management: a roadmap for one nyc hospital's response to the covid-19 pandemic Barbara Barnett
Yvette Calderon
Erick Eiting
Young Lee
Lina Miyakawa
Waleed Javaid and Saralynne Brown; 4. Contribution of radx to the rapid development and commercialization of covid-19 diagnostic assays Steven Schachter
John Collins
Michael Dempsey
Laura Gibson
Matthew Robinson and Paul Tessier; 5. Coordination of resources for the deployment of covid-19 diagnostic assays Brian Walsh
Maren Downing
Mia Cirrincoine
Adam Samuta
Kevin Leite
Sam Dolphin
Emily Muth and Jose Valdesuso; 6. Quality and risk management processes for diagnostic assays during an emergency pandemic response¿ Devon Campbell and Christie Johnson; 7. Development of assays to diagnose covid-19 Yuka Manabe and William Clarke; 8. Laboratory verification and clinical validation of covid-19 diagnostic assays Wilbur Lam
Leda Bassit
Anuradha Rao
Jennifer Frediani and Julie Sullivan; 9. Importance of timely sequencing
tracking and surveillance of emergent variants Anne Piantadosi
Jessica Lin
Morgan Greenleaf
Leda Bassit
Cassandra Wesselman and Yang Lu; 10. The RADx regulatory core and its role in covid-19 emergency use authorizations Erika Tyburski and Cathy Cambria; 11. Commercialization and market assessment of covid-19 assays Manuel Kingsley
Sunshine Moore and Heath Naquin; 12. Testing strategies to mitigate covid-19 disease spread Paul Tessier and Peko Hosoi; 13. A pandemic not just of infection but of inequality: the social impact of covid-19 Mara Aspinall and Liz Ruark; 14. Summary and path forward for future pandemics Wade Bolton and Steven Schachter.
response
and surveillance of the covid-19 pandemic crisis Enrique Rabellino
Alexandra Smith and Marta Cohen; 2. Immune system responses to SARS-CoV-2 Adolfo Firpo-Betancourt; 3. Clinical management: a roadmap for one nyc hospital's response to the covid-19 pandemic Barbara Barnett
Yvette Calderon
Erick Eiting
Young Lee
Lina Miyakawa
Waleed Javaid and Saralynne Brown; 4. Contribution of radx to the rapid development and commercialization of covid-19 diagnostic assays Steven Schachter
John Collins
Michael Dempsey
Laura Gibson
Matthew Robinson and Paul Tessier; 5. Coordination of resources for the deployment of covid-19 diagnostic assays Brian Walsh
Maren Downing
Mia Cirrincoine
Adam Samuta
Kevin Leite
Sam Dolphin
Emily Muth and Jose Valdesuso; 6. Quality and risk management processes for diagnostic assays during an emergency pandemic response¿ Devon Campbell and Christie Johnson; 7. Development of assays to diagnose covid-19 Yuka Manabe and William Clarke; 8. Laboratory verification and clinical validation of covid-19 diagnostic assays Wilbur Lam
Leda Bassit
Anuradha Rao
Jennifer Frediani and Julie Sullivan; 9. Importance of timely sequencing
tracking and surveillance of emergent variants Anne Piantadosi
Jessica Lin
Morgan Greenleaf
Leda Bassit
Cassandra Wesselman and Yang Lu; 10. The RADx regulatory core and its role in covid-19 emergency use authorizations Erika Tyburski and Cathy Cambria; 11. Commercialization and market assessment of covid-19 assays Manuel Kingsley
Sunshine Moore and Heath Naquin; 12. Testing strategies to mitigate covid-19 disease spread Paul Tessier and Peko Hosoi; 13. A pandemic not just of infection but of inequality: the social impact of covid-19 Mara Aspinall and Liz Ruark; 14. Summary and path forward for future pandemics Wade Bolton and Steven Schachter.